Merck & Co Inc (NYSE:MRK)
| 76.93 Delayed Data As of 4:06pm ET |  -0.02 / -0.03%Today’s Change | 65.25 Today|||52-Week Range 92.64 | -15.42% Year-to-Date |
Latest MRK News | Press Releases
No recent news for Merck & Co Inc.
Today’s Trading
| Previous close | 76.95 |
| Today’s open | 76.25 |
| Day’s range | 75.54 - 77.60 |
| Volume | 14,368,562 |
| Average volume (3 months) | 11,759,447 |
| Market cap | -- |
Data as of 4:06pm ET, 03/31/2020
Growth & Valuation
| Earnings growth (last year) | +64.36% |
| Earnings growth (this year) | +10.02% |
| Earnings growth (next 5 years) | +8.50% |
| Revenue growth (last year) | +9.75% |
| P/E ratio | 20.2 |
| Price/Sales | 5.04 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | +0.49 | +0.60% |
| PFEPfizer | +0.03 | +0.09% |
| LLYEli Lilly and Co | +0.18 | +0.13% |
| BMYBristol-Myers Squibb | +1.36 | +2.50% |
Data as of 4:11pm ET, 03/31/2020
Financials
| Next reporting date | April 28, 2020 |
| EPS forecast (this quarter) | $1.35 |
| Annual revenue (last year) | $46.6B |
| Annual profit (last year) | $9.8B |
| Net profit margin | 21.13% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
Forecasts
